This case, together with a DePuy ASR hip lawsuit currently at trial in Illinois, and others set to begin this year in the MDL proceeding, are significant steps forward in this litigation.
New York, New York (PRWEB) April 11, 2013
Bernstein Liebhard LLP notes that a California Superior Court judge has issued the final Judgment in the nation’s first trial involving a DePuy ASR hip lawsuit. According to Judge J. Stephen Czuleger's Judgment dated April 1st, the jury’s original compensatory damage award was reduced by $77,345.27, following agreement of both parties. However, the $8 million in non-economic damages awarded to the Plaintiff in the DePuy ASR lawsuit will stand. (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County (Los Angeles))
“We are extremely pleased with the outcome of this trial. This case, together with a DePuy ASR hip lawsuit currently at trial in Illinois, and others set to begin this year in the MDL proceeding, are significant steps forward in this litigation and will provide valuable insight into how juries might rule in similar claims," says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently representing scores of clients in DePuy ASR lawsuits, and continues to offer free case evaluations to alleged victims of the DePuy ASR hip recall.
DePuy ASR Hip Recall
According to Bloomberg.com, the California case was the first of more than 10,700 lawsuits filed since the DePuy ASR hip recall to head to trial. The metal-on-metal hip implant was recalled in August 2010, after it was found to be failing early in an unacceptably high number of patients. During the trial, evidence was introduced on behalf of the Plaintiff that called into question assertions made by Johnson & Johnson and its DePuy Orthopedics unit that the issues with the ASR line hip implants were handled properly, including documents that indicated the DePuy ASR’s early failure rate could near 40%.*
Following the DePuy ASR recall, the U.S. Food & Drug Administration (FDA) launched a safety review of metal-on-metal hip implants. In January, the agency advised doctors to consider metal ion testing in those experiencing symptoms of hip implant failure. The FDA also said it had proposed a new rule that would make all-metal hips ineligible for the agency’s 510(k) clearance process, which allowed all-metal hips to come to market without human testing.**
The DePuy ASR hip replacement lawyers at Bernstein Liebhard LLP are actively filing claims in a multidistrict litigation underway in U.S. District Court, Northern District of Ohio. According to court records, the first trials in that litigation are to begin this spring. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197) A second DePuy ASR hip recall trial is currently underway in Illinois’ Cook County Circuit Court, and is expected to conclude soon. (In Re DePuy ASR Hip Litigation, No. 10-L-10506)
Alleged victims of the DePuy ASR hip recall may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information regarding DePuy ASR hip lawsuits is available on Bernstein Liebhard LLP’s website. For additional information, please contact one of our attorneys by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP